[Safety and efficacy of thrombolysis during ambulance transportation of patients with an acute heart infarct]. / De veiligheid en effectiviteit van trombolyse tijdens ambulancetransport van patiënten met een acuut hartinfarct.
Ned Tijdschr Geneeskd
; 133(7): 354-8, 1989 Feb 18.
Article
en Nl
| MEDLINE
| ID: mdl-2927553
ABSTRACT
We studied the safety and efficacy of thrombolytic therapy for acute myocardial infarction initiated prior to ambulance transport. Intravenous streptokinase with 5 X 10(5) IU (SK-i.v.) was started in 40 patients (group A) before transport and 36 patients (group B) after transport. In all patients immediate coronary angiography was performed, followed by intracoronary streptokinase. Infarct size was assessed from cumulative release of alpha-hydroxybutyrate dehydrogenase. No procedure-related complications were seen during transport. The time to SK-i.v. was 70 minutes in group A versus 125 minutes in group B. At first visualisation the infarct-related vessel was patent in 23 patients (58%) in group A and in 6 patients (17%) in group B (p less than 0.001). For anterior wall infarction we found a 32% smaller infarct size in group A (p less than 0.05). We conclude that SK-i.v. during ambulance transport is safe, increases early reperfusion and leads to a further reduction of infarct size which is significant in anterior wall infarction.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Estreptoquinasa
/
Transporte de Pacientes
/
Infarto del Miocardio
Tipo de estudio:
Clinical_trials
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Nl
Revista:
Ned Tijdschr Geneeskd
Año:
1989
Tipo del documento:
Article